These results are in line with reports of chronically stimulated tissue-resident CD8+ populations that retain proliferative capacity and are thought to be involved in tumour control30,31 and that have been associated with better prognosis and tumour reactivity in pMMR CRC51,52. The gene discussed is CD8A; the disease is neoplasm.